High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: An initial foray

Clinica Chimica Acta

Volumn 411, Issue 11-12, 2010, Pages 812-817

  Schulz, Olaf ^a   Reinicke, Markus ^a   Berghoefer, Gunnar H ^a   Bensch, Ricarda ^a   Kraemer, Jochen ^a   Schimke, Ingolf ^b   Jaffe, Allan S ^c  

^a Interventionelle Kardiologie Spandau   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Chronic cardiac disease; High sensitivity troponin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN; TROPONIN I; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; WALL STRESS; AGED; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; HEART MUSCLE; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TROPONIN I;

EID: 77956460987     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.02.066     Document Type: Article

References (35)

1. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000, 21:1502-1513.
2. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007, 28:2525-2538.
3. Smith S.C., Ladenson J.H., Mason J.W., Jaffe A.S. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997, 95:163-168.
4. Konstantinides S., Geibel A., Olschewski M., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002, 106:1263-1268.
5. Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
6. Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
7. Kavsak P.A., Macrae A.R., Yerna M.J., Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009, 55:573-577.
8. Schulz O., Paul-Walter C., Lehmann M., et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol 2007, 100:764-769.
9. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52:450-459.
10. Latini R., Masson S., Anand I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
11. Jeremias A., Kleiman N.S., Nassif D., et al. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation 2008, 118:632-638.
12. Hsieh B.P., Rogers A.M., Na B., Wu A.H., Schiller N.B., Whooley M.A. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study. Am Heart J 2009, 158:673-679.
13. Wu A.H., Jaffe A.S. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008, 155:208-214.
14. Wu A.H., Fukushima N., Puskas R., Todd J., Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescent detector. Clin Chem 2006, 52:2157-2159.
15. Jaffe A.S. Chasing troponin: how low can you go if you can see the rise?. J Am Coll Cardiol 2006, 48:1763-1764.
16. Omland T., de Lemos J.A., Sabatine M.S., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
17. Fletcher G.F., Balady G.J., Amsterdam E.A., et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001, 104:1694-1740.
18. Gibbons R.J., Balady G.J., Timothy Bricker J., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002, 40:1531-1540.
19. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
20. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003, 42:954-970.
21. Bashore T.M., Bates E.R., Berger P.B., et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:2170-2214.
22. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
23. Reichek N., Wilson J., St John Sutton M., Plappert T.A., Goldberg S., Hirshfeld J.W. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982, 65:99-108.
24. Kalra D.K., Ramchandani M., Zhu X., et al. Relation of tissue Doppler-derived myocardial velocities to serum levels and myocardial gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase in patients with ischemic cardiomyopathy having coronary artery bypass grafting. Am J Cardiol 2002, 90:708-712.
25. Smith S.C., Dove J.T., Jacobs A.K., et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 2001, 37:2215-2239.
26. Venge P., Johnston N., Lindahl B., James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009, 54:1165-1172.
27. Omland T., de Lemos J.A., Sabatine M.S., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
28. Eggers K.M., Lagerqvist B., Oldgren J., Venge P., Wallentin L., Lindahl B. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008, 156:588-594.
29. Feng J., Schaus B.J., Fallavollita J.A., Lee T.C., Canty J.M. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001, 103:2035-2037.
30. Miller W.L., Hartman K.A., Burritt M.F., et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007, 116:249-257.
31. Kurz K., Giannitsis E., Zehelein J., Katus H.A. Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. Clin Chem 2008, 54:1234-1238.
32. Sabatine M.S., Morrow D.A., de Lemos J.A., Jarolim P., Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009, 30:162-169.
33. Forrester J.S. Toward understanding the evolution of plaque rupture: correlating vascular pathology with clinical outcomes. J Am Coll Cardiol 2003, 42:1566-1568.
34. Zethelius B., Johnston N., Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006, 113:1071-1078.
35. Hemingway H., Crook A.M., Banerjee S., et al. Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study. Heart 2001, 85:672-679.